Drug recall · September 25, 2019
Oxcarbazepine Oral Suspension recall
Why: Failed Impurities/Degradation Specificattion
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatontown, NJ. NDC:0054-0199-59
- Lots / codes
Lot, expiry: Lots AA3957A, AA3958A, exp May 2020; Lot AA5164A, exp Sep 2020
- Quantity
- 32,347 bottles
- Company
- West-Ward Columbus Inc, Columbus, OH
- Distribution
- Nationwide USA and Puerto Rico
- Initiated
- September 9, 2019 · Voluntary: Firm initiated
- Classified
- September 16, 2019
- Reported
- September 25, 2019
- Ended
- June 15, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Oxcarbazepine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.